NASDAQ · SPTX
Seaport Therapeutics, Inc.
$19.86 Last insider buy price, paid by Director Denice Torres on Nov 3 (Form 4). Live prices are not shown yet.
Smart money pulse
What insiders and funds are doing
Buying Insiders: as of Nov 12 Funds: as of Jun 30, 2026
- group1 insider bought in the last 30 days. $99.3K in open-market buys, Nov 3.
- infoNo real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.
Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then. This is data, not advice.
Who owns it
55 funds report owning SPTX
Insider trades · last 12 months
Real buys and sales
● Open-market buy● Open-market sale
Showing 1 real trades. Bigger dot means a bigger trade.
Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.
Top holders
Biggest funds in SPTX
| Fund | Owns | Value | Change |
|---|---|---|---|
| ARCH Venture Management, LLC | — | $137M | |
| General Atlantic, L.p. | — | $133M | |
| Sofinnova Investments, Inc. | — | $77.4M | |
| Goldman Sachs Group INC | — | $47.3M | |
| Trv Gp Vi, LLC | — | $44.8M |
"Owns" is shares reported divided by shares outstanding.